Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about STRESS RESPONSE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | STRESS RESPONSE |
graph TD
STRESS_RESPONSE[STRESS RESPONSE]
STRESS_RESPONSE -->|activates| Hypothalamic_pituitary_adrenal[Hypothalamic-pituitary-adrenal axis]
STRESS_RESPONSE -->|contributes to| Alopecia_Areata[Alopecia Areata]
STRESS_RESPONSE -->|contributes to| Brain_Aging[Brain Aging]
STRESS_RESPONSE -->|activates| Hematopoietic_Stem_Cells[Hematopoietic Stem Cells]
STRESS_RESPONSE -->|activates| Hematopoietic_Progenitor_Cells[Hematopoietic Progenitor Cells]
STRESS_RESPONSE -->|involved_in| ALS[ALS]
Hypothalamic_Pituitary_Adrenal[Hypothalamic-Pituitary-Adrenal Axis] -->|mediates| STRESS_RESPONSE
Sympathetic_Adrenal_Medullary_[Sympathetic-Adrenal-Medullary Axis] -->|mediates| STRESS_RESPONSE
CRF[CRF] -->|mediates| STRESS_RESPONSE
P53[P53] -->|regulates| STRESS_RESPONSE
hippocampus[hippocampus] -->|involved_in| STRESS_RESPONSE
Mitochondrial_Hk_Anchoring[Mitochondrial Hk Anchoring] -->|mediates| STRESS_RESPONSE
TP53[TP53] -->|regulates| STRESS_RESPONSE
hematopoietic_stem_and_progeni[hematopoietic stem and progenitor cells] -->|mediates| STRESS_RESPONSE
Locus_Coeruleus[Locus Coeruleus] -->|mediates| STRESS_RESPONSE
NR3C1[NR3C1] -->|mediates| STRESS_RESPONSE| Target | Relation | Type | Str |
|---|---|---|---|
| Hypothalamic-pituitary-adrenal axis | activates | pathway | 0.90 |
| Alopecia Areata | contributes_to | disease | 0.88 |
| Brain Aging | contributes_to | process | 0.85 |
| Hematopoietic Stem Cells | activates | cell_type | 0.80 |
| Hematopoietic Progenitor Cells | activates | cell_type | 0.80 |
| ALS | involved_in | disease | 0.75 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Hypothalamic-Pituitary-Adrenal Axis | mediates | pathway | 0.95 |
| Sympathetic-Adrenal-Medullary Axis | mediates | pathway | 0.95 |
| CRF | mediates | protein | 0.90 |
| hippocampus | involved_in | brain_region | 0.90 |
| P53 | regulates | protein | 0.90 |
| Mitochondrial Hk Anchoring | mediates | mechanism | 0.88 |
| TP53 | regulates | gene | 0.85 |
| Oligodendrocytes | associated_with | cell_type | 0.85 |
| hematopoietic stem and progenitor cells | mediates | cell_type | 0.85 |
| G3BP1 | involved_in | protein | 0.80 |
| mitochondrial anchoring | mediates | process | 0.80 |
| Locus Coeruleus | mediates | structure | 0.80 |
| NR3C1 | mediates | gene | 0.80 |
| Psychobiotics | treats | drug | 0.70 |
| NR3C1 | regulates | gene | 0.70 |
| CRH | regulates | gene | 0.70 |
| NR3C1 | regulates | gene | 0.60 |
| CRH | involved_in | protein | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| eIF2α Phosphorylation Imbalance Creates Integrated Stress Re | 0.896 | ALS | - |
| Multi-Modal Stress Response Harmonization | 0.756 | neurodegeneration | Digital biomarkers and AI-driven early d |
| NRF2-Mediated Proteostatic Convergence: Shared Oxidative Str | 0.700 | neurodegeneration | - |
| Nucleolar Stress Response Normalization | 0.653 | neurodegeneration | RNA binding protein dysregulation across |
| TOM/TIM Complex Disruption Triggering Mitochondrial Integrat | 0.622 | neurodegeneration | What upstream mechanisms cause TDP-43 to |
| Neuronal Integrated Stress Response Modulation | 0.526 | neurodegeneration | Cell type vulnerability in Alzheimer's D |
| Oligodendrocyte Stress Response Uniformity | 0.455 | neuroinflammation | Why do clinical manifestations overlap d |
| Ribosomal Stress Response Exploitation | 0.455 | neurodegeneration | How do host cell factors influence the c |
| TBK1 Loss Triggers eIF2α-Mediated Translational Repression T | 0.000 | ALS | What are the mechanisms by which microgl |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Gestational haloperidol exposure effects on hippocampal gene expressio | validation | schizophrenia | 0.900 | 0.00 | pregnant mice and offspring | proposed | N/A |
| NPM1-IRF1 protein interaction validation | exploratory | cancer | 0.900 | 0.00 | cultured cells | proposed | N/A |
| NPM1 knockout tumor progression study in syngeneic mice | validation | cancer | 0.900 | 0.00 | syngeneic mice with subcutaneo | proposed | N/A |
| Dual-luciferase assay for miR-137-3p target validation | exploratory | schizophrenia | 0.800 | 0.00 | cell culture system with dual- | proposed | N/A |
| In vitro T-cell killing assay with OVA-presenting tumor cells | exploratory | cancer | 0.800 | 0.00 | OVA-presenting tumor cells and | proposed | N/A |
| Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe | clinical | Neurodegeneration | 0.400 | 0.50 | in_silico | proposed | $180,000 |
| Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts | clinical | ALS | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Animal Model Comparison for Neurodegenerative Disease Therapeutics | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $7,100,000 |
| Experiment: Autoimmune Hypothesis Testing in AD | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Experiment Index | validation | Neurodegeneration | 0.400 | 0.50 | human | proposed | $2,280,000 |
| N-of-1 Clinical Trial Design for CBS/PSP | clinical | ALS | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Experiment Scoring Methodology | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Traumatic Brain Injury and Alzheimer's Disease Relationship | validation | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $3,000,000 |
| DNA Damage Repair Deficiency Validation Study in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | completed | $7,500,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor p [PMID:39402629] | Wang X, Chai Y, Quan Y, Wang J, Song J, | J Hematol Oncol | 2024 | 1 |
| Significance of NPM1 Gene Mutations in AML. [PMID:34576201] | Hindley A, Catherwood MA, McMullin MF, M | Int J Mol Sci | 2021 | 1 |
| NPM1-mutated acute myeloid leukemia: from bench to bedside. [PMID:32609823] | Falini B, Brunetti L, Sportoletti P, Mar | Blood | 2020 | 1 |
| Methylation of HPA axis related genes in men with hypersexual disorder. [PMID:28319850] | Jokinen J, Boström AE, Chatzittofis A, C | Psychoneuroendocrinology | 2017 | 1 |
| Insights into the regulation of neuronal viability by nucleophosmin/B23. [PMID:25908633] | Pfister JA, D'Mello SR | Exp Biol Med (Maywood) | 2015 | 1 |
| Development of alopecia areata is associated with higher central and peripheral [PMID:19020552] | Zhang X, Yu M, Yu W, Weinberg J, Shapiro | J Invest Dermatol | 2009 | 1 |
| Functions of the histone chaperone nucleolin in diseases. [PMID:17484127] | Storck S, Shukla M, Dimitrov S, Bouvet P | Subcell Biochem | 2007 | 1 |
| Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypome [PMID:41035402] | Short NJ, Loghavi S, Yilmaz M, Karrar O, | Haematologica | 2026 | 0 |
| A Unified Model: Chromatin-Bound Multicomponent Condensates. [PMID:41481253] | Lau BK, Haarer EL, Ahn JH, Wang GG | Cancer Res | 2026 | 0 |
| Targeting the Menin-KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to [PMID:41923577] | Bruzzese A, Vigna E, Martino EA, Caserta | Eur J Haematol | 2026 | 0 |
| Response to Comment on: "Prognostic implications of myelodysplasia-related gene [PMID:41924903] | Chang YS, Hou HA | Haematologica | 2026 | 0 |
| Cytokine associated neuroinflammation in Parkinson's disease: Molecular pathways [PMID:41512596] | ["Dhapola R", "Kumari S", "Sharma P", "P | Cytokine & growth factor revie | 2026 | 0 |
| Fibrillarin: bridging ribosome biogenesis and apoptosis in cellular stress and d [PMID:41518572] | ["Zhang Z", "Zhang M", "Cao Z", "Zhao H" | Apoptosis : an international j | 2026 | 0 |
| Neurobiological and therapeutic landmarks of depression associated with Alzheime [PMID:40529210] | ["Untu I", "Davidson M", "Stanciu G", "R | Frontiers in aging neuroscienc | 2025 | 0 |
| Neurobiological mechanisms and recent advances in drug-based therapeutics in dep [PMID:41205901] | ["Ahmadnia H", "Abdollahzadeh R", "Hatam | Neuroscience | 2025 | 0 |
| Probing condensate microenvironments with a micropeptide killswitch. [PMID:40468084] | Zhang Y, Stöppelkamp I, Fernandez-Pernas | Nature | 2025 | 0 |
| Functions of the native NPM1 protein and its leukemic mutant. [PMID:39690184] | Falini B, Sorcini D, Perriello VM, Sport | Leukemia | 2025 | 0 |
| Multi-Target Protective Effects of β-Caryophyllene (BCP) at the Intersection of [PMID:40649806] | ["Ricardi C", "Mazzierli A", "Guglielmo | International journal of molec | 2025 | 0 |
| A novel multi-target compound mitigates amyloid plaques, synaptic deficits, and [PMID:40770166] | ["Lee Y", "Han S", "Lee J", "Cho Y", "Ki | Archives of pharmacal research | 2025 | 0 |
| Beyond Pulmonary Vein Reconnection: Exploring the Dynamic Pathophysiology of Atr [PMID:40363950] | ["Vlachakis P", "Theofilis P", "Apostolo | Journal of clinical medicine | 2025 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning STRESS RESPONSE in their description or question text
Score: 0.526 · neurodegeneration · 2026-04-04
## Mechanistic Overview Neuronal Integrated Stress Response Modulation starts from the claim that modulating EIF2AK3 (PE
Score: 0.455 · neuroinflammation · 2026-04-27
Different myelopathy etiologies trigger conserved oligodendrocyte stress response program mediated by ER stress and inte
Score: 0.455 · neurodegeneration · 2026-04-27
Selective activation of ribosome-associated quality control pathways to eliminate seed-templated nascent proteins
Score: 0.000 · ALS · 2026-04-28
This hypothesis proposes that TBK1 loss-of-function mutations drive ALS pathogenesis through a two-step mechanism: first